Br J Cardiol 2010;17:73–5
Until recently, supportive and palliative care for patients with heart failure has been neglected in primary and secondary care. Patients dying from cancer have benefited...
Br J Cardiol 2010;17:76–80
Plasma natriuretic peptide (NP) testing is not widely used in heart failure clinical practice in the UK or Ireland, despite a large evidence base. This...
Br J Cardiol 2010;17:21
News in brief from the world of...
Br J Cardiol 2008;15: 322–5
Heart failure (HF) is an important cause of morbidity and mortality in the general hospital setting worldwide. The paucity of data on psychiatric co-morbidity in...
Br J Cardiol 2008;15:231-36
Highlights of the European Society of Cardiology meeting held in Munich, Germany, August 30th – September 3rd 2008 showed further benefit for fish oils, this...
Br J Cardiol 2008;15:261-5
Renal artery stenosis is a condition that has significant effects on the progression and outcomes of co-existent cardiac disease. The most important cause of renal...
Br J Cardiol 2008;15:179–80
Clinicians find heart failure difficult to diagnose.1 Confirmation of left ventricular dysfunction (systolic or diastolic) is only possible by cardiac imaging. Recent European Society of...
Br J Cardiol 2008;15:101-5
The Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) showed that addition of eplerenone to optimal medical therapy reduced morbidity and mortality...
Br J Cardiol 2008;15:6
There is a need to meet the demand, led by primary care, for the appropriate assessment and management of patients with heart failure. Standard 11...
Br J Cardiol 2008;15:35-9
Heart failure (HF) is common and the current gold-standard diagnostic modality for left ventricular systolic dysfunction (LVSD) is transthoracic echocardiography (TTE). To comply with the...